Follow
Hamid Irannejad
Hamid Irannejad
Research Scientist of Medicinal Chemistry, Mazandaran University of Medical Sciences
Verified email at mazums.ac.ir
Title
Cited by
Cited by
Year
Synthesis and in vitro evaluation of novel 1, 2, 4-triazine derivatives as neuroprotective agents
H Irannejad, M Amini, F Khodagholi, N Ansari, SK Tusi, M Sharifzadeh, ...
Bioorganic & medicinal chemistry 18 (12), 4224-4230, 2010
1002010
Toward the discovery of novel anti‐HIV drugs. Second‐generation inhibitors of the cellular ATPase DDX3 with improved anti‐HIV activity: Synthesis, structure–activity …
G Maga, F Falchi, M Radi, L Botta, G Casaluce, M Bernardini, H Irannejad, ...
ChemMedChem 6 (8), 1371-1389, 2011
992011
Mannich bases of 7-piperazinylquinolones and kojic acid derivatives: synthesis, in vitro antibacterial activity and in silico study
S Emami, E Ghafouri, MA Faramarzi, N Samadi, H Irannejad, ...
European journal of medicinal chemistry 68, 185-191, 2013
802013
Design, synthesis, in vivo and in silico evaluation of phenacyl triazole hydrazones as new anticonvulsant agents
L Dehestani, N Ahangar, SM Hashemi, H Irannejad, PH Masihi, ...
Bioorganic chemistry 78, 119-129, 2018
532018
Synthesis, docking simulation, biological evaluations and 3D-QSAR study of 5-Aryl-6-(4-methylsulfonyl)-3-(metylthio)-1, 2, 4-triazine as selective cyclooxygenase-2 inhibitors
H Irannejad, A Kebriaieezadeh, A Zarghi, F Montazer-Sadegh, A Shafiee, ...
Bioorganic & Medicinal Chemistry 22 (2), 865-873, 2014
492014
Synthesis, in vitro antifungal evaluation and in silico study of 3-azolyl-4-chromanone phenylhydrazones
A Ayati, M Falahati, H Irannejad, S Emami
DARU Journal of Pharmaceutical Sciences 20, 1-7, 2012
472012
Inhibition of LPS-induced apoptosis in differentiated-PC12 cells by new triazine derivatives through NF-κB-mediated suppression of COX-2
N Ansari, F Khodagholi, M Ramin, M Amini, H Irannejad, L Dargahi, ...
Neurochemistry international 57 (8), 958-968, 2010
402010
Synthesis and biological evaluation of fluconazole analogs with triazole-modified scaffold as potent antifungal agents
SM Hashemi, H Badali, H Irannejad, M Shokrzadeh, S Emami
Bioorganic & Medicinal Chemistry 23 (7), 1481-1491, 2015
372015
Novel triazole alcohol antifungals derived from fluconazole: design, synthesis, and biological activity
SM Hashemi, H Badali, MA Faramarzi, N Samadi, MH Afsarian, ...
molecular diversity 19 (1), 15-27, 2015
372015
Microwave-assisted synthesis and anticonvulsant activity of 5, 6-bisaryl-1, 2, 4-triazine-3-thiol derivatives
H Irannejad, N Naderi, S Emami, RQ Ghadikolaei, A Foroumadi, T Zafari, ...
Medicinal Chemistry Research 23, 2503-2514, 2014
372014
Anticonvulsant activity of 1, 2, 4-triazine derivatives with pyridyl side chain: synthesis, biological, and computational study
H Irannejad, H Nadri, N Naderi, SN Rezaeian, N Zafari, A Foroumadi, ...
Medicinal Chemistry Research 24, 2505-2513, 2015
352015
Imidazolylchromanones containing non-benzylic oxime ethers: Synthesis and molecular modeling study of new azole antifungals selective against Cryptococcus gattii
M Babazadeh-Qazijahani, H Badali, H Irannejad, MH Afsarian, S Emami
European Journal of Medicinal Chemistry 76, 264-273, 2014
332014
Synthesis, in vitro antifungal activity and in silico study of 3-(1, 2, 4-triazol-1-yl) flavanones
S Emami, S Shojapour, MA Faramarzi, N Samadi, H Irannejad
European Journal of Medicinal Chemistry 66, 480-488, 2013
332013
Design, Synthesis and In Vitro Study of 5,6‐Diaryl‐1,2,4‐triazine‐3‐ylthioacetate Derivatives as COX‐2 and β‐Amyloid Aggregation Inhibitors
S Dadashpour, T Tuylu Kucukkilinc, O Unsal Tan, K Ozadali, H Irannejad, ...
Archiv der Pharmazie 348 (3), 179-187, 2015
282015
Synthesis and neuroprotective activity of novel 1,2,4-triazine derivatives with ethyl acetate moiety against H 2 O2 and Aβ-induced neurotoxicity
T Tuylu Kucukkilinc, K Safari Yanghagh, B Ayazgok, M Ali Roknipour, ...
Medicinal Chemistry Research 26, 3057-3071, 2017
182017
Potentiation of low-dose doxorubicin cytotoxicity by affecting p-glycoprotein through caryophyllane sesquiterpenes in hepg2 cells: An in vitro and in silico study
A Di Sotto, H Irannejad, M Eufemi, R Mancinelli, L Abete, CL Mammola, ...
International Journal of Molecular Sciences 21 (2), 633, 2020
172020
Synthesis, in silico, in vitro and in vivo evaluations of isatin aroylhydrazones as highly potent anticonvulsant agents
S Emami, M Valipour, FK Komishani, F Sadati-Ashrafi, M Rasoulian, ...
Bioorganic Chemistry 112, 104943, 2021
152021
The neuroprotective effect of a triazine derivative in an Alzheimer's rat model
F Alipour, S Oryan, M Sharifzadeh, F Karimzadeh, L Kafami, H Irannejad, ...
Acta Medica Iranica, 8-16, 2015
152015
Therapeutic potential of chelerythrine as a multi-purpose adjuvant for the treatment of COVID-19
M Valipour, A Zarghi, MA Ebrahimzadeh, H Irannejad
Cell Cycle 20 (22), 2321-2336, 2021
142021
Imidazolylchromanones containing alkyl side chain as lanosterol 14α-demethylase inhibitors: synthesis, antifungal activity and docking study
S Emami, T Banipoulad, H Irannejad, A Foroumadi, M Falahati, ...
Journal of Enzyme Inhibition and Medicinal Chemistry 29 (2), 263-271, 2014
142014
The system can't perform the operation now. Try again later.
Articles 1–20